Skip to main content
Top
Published in: BMC Hematology 1/2012

Open Access 01-12-2012 | Case report

Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report

Authors: Eva Gupta, Michael Yacoub, Martha Higgins, Ayad M Al-Katib

Published in: BMC Hematology | Issue 1/2012

Login to get access

Abstract

Background

Syncytial giant cell hepatitis (GCH) is an uncommon and an underreported disease entity. In two previously reported cases of GCH in patients with Chronic Lymphocytic Leukemia (CLL) liver failure ensued. Autoimmune and infective causes have been implicated but its etiology remains unclear.

Case Presentation

A 60-year-old female with CLL presented with acute hepatitis with negative viral and auto-immune serologies and without any prior toxic exposure. Liver biopsy showed typical histological features of GCH. The patient was successfully treated with corticosteroids and intravenous immunoglobulin (IVIG). Her liver enzymes returned to baseline and have remained normal as of the last follow up almost 4 years later.

Conclusions

Association of GCH with CLL may be under recognized. Clinical suspicion of GCH in CLL patients with serology-negative hepatitis, early liver biopsy and therapeutic intervention may influence outcome. This is the first case report of successful treatment of GCH in CLL patients. Moreover, our case also demonstrates the ability to resume effective CLL therapy post-GCH diagnosis without detriment to the liver.
Appendix
Available only for authorised users
Literature
1.
go back to reference Phillips MJ, Blendis LM, Poucell S, Offterson J, Petric M, Roberts E, Levy GA, Superina RA, Greig PD, Cameron R: Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med. 1991, 324: 455-460. 10.1056/NEJM199102143240705.CrossRefPubMed Phillips MJ, Blendis LM, Poucell S, Offterson J, Petric M, Roberts E, Levy GA, Superina RA, Greig PD, Cameron R: Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med. 1991, 324: 455-460. 10.1056/NEJM199102143240705.CrossRefPubMed
2.
go back to reference Thaler H: Post-infantile giant cell hepatitis. Liver. 1982, 2: 393-403.PubMed Thaler H: Post-infantile giant cell hepatitis. Liver. 1982, 2: 393-403.PubMed
3.
go back to reference Johnson SJ, Mathew J, MacSween RN, Bennett MK, Burt AD: Post-infantile giant cell hepatitis: histological and immunohistochemical study. J Clin Pathol. 1994, 47: 1022-1027. 10.1136/jcp.47.11.1022.CrossRefPubMedPubMedCentral Johnson SJ, Mathew J, MacSween RN, Bennett MK, Burt AD: Post-infantile giant cell hepatitis: histological and immunohistochemical study. J Clin Pathol. 1994, 47: 1022-1027. 10.1136/jcp.47.11.1022.CrossRefPubMedPubMedCentral
4.
go back to reference Protzer U, Dienes HP, Bianchi L, Lohse AW, Helmreich-Becker I, Gerken G, Meyer zum Buschenfelde KH: Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver. 1996, 16: 274-282.CrossRefPubMed Protzer U, Dienes HP, Bianchi L, Lohse AW, Helmreich-Becker I, Gerken G, Meyer zum Buschenfelde KH: Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver. 1996, 16: 274-282.CrossRefPubMed
5.
go back to reference Fimmel CJ, Guo L, Compans RW, Brunt EM, Hickman S, Perrillo RR, Mason AL: A case of syncytial giant cell hepatitis with features of a paramyxoviral infection. Am J Gastroenterol. 1998, 93: 1931-1937. 10.1111/j.1572-0241.1998.00548.x.CrossRefPubMed Fimmel CJ, Guo L, Compans RW, Brunt EM, Hickman S, Perrillo RR, Mason AL: A case of syncytial giant cell hepatitis with features of a paramyxoviral infection. Am J Gastroenterol. 1998, 93: 1931-1937. 10.1111/j.1572-0241.1998.00548.x.CrossRefPubMed
6.
go back to reference Bianchi L, Terracciano LM: Giant cell hepatitis in adults. Praxis (Bern 1994). 1994, 83: 1237-1241. Bianchi L, Terracciano LM: Giant cell hepatitis in adults. Praxis (Bern 1994). 1994, 83: 1237-1241.
7.
go back to reference Kryczka W, Zarebska-Michaluk D, Chrapek M: Assessment of selected clinical factors as predictors of response to combined interferon-alpha plus ribavirin therapy among patients with chronic hepatitis C. Med Sci Monit. 2003, 9 (Suppl 3): 32-35.PubMed Kryczka W, Zarebska-Michaluk D, Chrapek M: Assessment of selected clinical factors as predictors of response to combined interferon-alpha plus ribavirin therapy among patients with chronic hepatitis C. Med Sci Monit. 2003, 9 (Suppl 3): 32-35.PubMed
8.
go back to reference Moreno A, Moreno A, Perez-Elias MJ, Quereda C, Fernandez-Munoz R, Antela A, Moreno L, Barcena R, Lopez-San Roman A, Celma ML, et al: Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature. Hum Pathol. 2006, 37: 1344-1349. 10.1016/j.humpath.2006.05.003.CrossRefPubMed Moreno A, Moreno A, Perez-Elias MJ, Quereda C, Fernandez-Munoz R, Antela A, Moreno L, Barcena R, Lopez-San Roman A, Celma ML, et al: Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature. Hum Pathol. 2006, 37: 1344-1349. 10.1016/j.humpath.2006.05.003.CrossRefPubMed
9.
go back to reference Horsmans Y, Brenard R, Ferrant A, Lagneaux G, Geubel AP: Long-term favourable outcome of portal hypertension complicating primary systemic amyloidosis. Liver. 1995, 15: 332-334.CrossRefPubMed Horsmans Y, Brenard R, Ferrant A, Lagneaux G, Geubel AP: Long-term favourable outcome of portal hypertension complicating primary systemic amyloidosis. Liver. 1995, 15: 332-334.CrossRefPubMed
10.
go back to reference Alexopoulou A, Deutsch M, Ageletopoulou J, Delladetsima JK, Marinos E, Kapranos N, Dourakis SP: A fatal case of postinfantile giant cell hepatitis in a patient with chronic lymphocytic leukaemia. Eur J Gastroenterol Hepatol. 2003, 15: 551-555.CrossRefPubMed Alexopoulou A, Deutsch M, Ageletopoulou J, Delladetsima JK, Marinos E, Kapranos N, Dourakis SP: A fatal case of postinfantile giant cell hepatitis in a patient with chronic lymphocytic leukaemia. Eur J Gastroenterol Hepatol. 2003, 15: 551-555.CrossRefPubMed
11.
go back to reference Ben-Ari Z, Broida E, Monselise Y, Kazatsker A, Baruch J, Pappo O, Skappa E, Tur-Kaspa R: Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis. Am J Gastroenterol. 2000, 95: 799-801. 10.1111/j.1572-0241.2000.01863.x.CrossRefPubMed Ben-Ari Z, Broida E, Monselise Y, Kazatsker A, Baruch J, Pappo O, Skappa E, Tur-Kaspa R: Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis. Am J Gastroenterol. 2000, 95: 799-801. 10.1111/j.1572-0241.2000.01863.x.CrossRefPubMed
12.
go back to reference Vajro P, Migliaro F, Ruggeri C, Di Cosmo N, Crispino G, Caropreso M, Vecchione R: Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options. Dig Liver Dis. 2006, 38: 846-850. 10.1016/j.dld.2005.09.013.CrossRefPubMed Vajro P, Migliaro F, Ruggeri C, Di Cosmo N, Crispino G, Caropreso M, Vecchione R: Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options. Dig Liver Dis. 2006, 38: 846-850. 10.1016/j.dld.2005.09.013.CrossRefPubMed
13.
go back to reference Lau JY, Koukoulis G, Mieli-Vergani G, Portmann BC, Williams R: Syncytial giant-cell hepatitis–a specific disease entity?. J Hepatol. 1992, 15: 216-219. 10.1016/0168-8278(92)90039-R.CrossRefPubMed Lau JY, Koukoulis G, Mieli-Vergani G, Portmann BC, Williams R: Syncytial giant-cell hepatitis–a specific disease entity?. J Hepatol. 1992, 15: 216-219. 10.1016/0168-8278(92)90039-R.CrossRefPubMed
14.
go back to reference Pappo O, Yunis E, Jordan JA, Jaffe R, Mateo R, Fung J, Demetris AJ: Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. Am J Surg Pathol. 1994, 18: 804-813. 10.1097/00000478-199408000-00007.CrossRefPubMed Pappo O, Yunis E, Jordan JA, Jaffe R, Mateo R, Fung J, Demetris AJ: Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. Am J Surg Pathol. 1994, 18: 804-813. 10.1097/00000478-199408000-00007.CrossRefPubMed
15.
go back to reference Morrison VA: Management of infectious complications in patients with chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2007, 40 (1): 332-338. Morrison VA: Management of infectious complications in patients with chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2007, 40 (1): 332-338.
16.
go back to reference Pisciotta AV, Jermain LF, Hinz JE: Chronic lymphocytic leukemia, hypogammaglobulinemia and autoimmune hemolytic anemia–an experiment of nature. Blood. 1960, 15: 748-757.PubMed Pisciotta AV, Jermain LF, Hinz JE: Chronic lymphocytic leukemia, hypogammaglobulinemia and autoimmune hemolytic anemia–an experiment of nature. Blood. 1960, 15: 748-757.PubMed
17.
go back to reference CLL Trialists' Collaborative Group: Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. J Natl Cancer Inst. 1999, 91: 861-868.CrossRef CLL Trialists' Collaborative Group: Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. J Natl Cancer Inst. 1999, 91: 861-868.CrossRef
18.
go back to reference Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y: Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. Leuk Res. 2006, 30: 1589-1590. 10.1016/j.leukres.2006.02.011.CrossRefPubMed Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y: Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. Leuk Res. 2006, 30: 1589-1590. 10.1016/j.leukres.2006.02.011.CrossRefPubMed
Metadata
Title
Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report
Authors
Eva Gupta
Michael Yacoub
Martha Higgins
Ayad M Al-Katib
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2012
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/1471-2326-12-8

Other articles of this Issue 1/2012

BMC Hematology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.